Lifeline BioTechnologies CEO Featured in Exclusive Interview with WallSt.net

NEW YORK, March 29  /PRNewswire/ -- On March 27, Jim Holmes, Chief Executive Officer for Lifeline BioTechnologies, Inc. (Pink Sheets: LBTN) updated the investment community in an exclusive interview with http://www.wallst.net/ .  Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.

To hear the interview in its entirety, visit http://www.wallst.net/ , and click on "Interviews."  The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window.

About Lifeline BioTechnologies, Inc.:

Lifeline BioTechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems.  These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions.  The company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care.

  For more information, please visit http://www.lbtn.com/ .

  About WallSt.net:


http://www.wallst.net/ is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc.  The website is a leading provider of financial news, media, tools and community-driven applications for investors.  http://www.wallst.net/ offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications.  In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies.  We are expecting to receive two hundred eighty dollars from Lifeline BioTechnologies, Inc. for the dissemination of this press release.  For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO ) 

http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO

http://photoarchive.ap.org/

DATASOURCE: WallStreet Direct, Inc.



CONTACT:  Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST



Web site:  http://www.wallst.net/disclaimer/disclaimer.asp 

Web site:  http://www.lbtn.com/ 

Web site:  http://www.wallst.net/ 

Copyright